These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 24954590)

  • 21. Synthesis and opioid activity of conformationally constrained dynorphin A analogues. 2. Conformational constraint in the "address" sequence.
    Arttamangkul S; Ishmael JE; Murray TF; Grandy DK; DeLander GE; Kieffer BL; Aldrich JV
    J Med Chem; 1997 Apr; 40(8):1211-8. PubMed ID: 9111295
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The dynorphin/κ-opioid receptor system and its role in psychiatric disorders.
    Tejeda HA; Shippenberg TS; Henriksson R
    Cell Mol Life Sci; 2012 Mar; 69(6):857-96. PubMed ID: 22002579
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dynorphin A as a potential endogenous ligand for four members of the opioid receptor gene family.
    Zhang S; Tong Y; Tian M; Dehaven RN; Cortesburgos L; Mansson E; Simonin F; Kieffer B; Yu L
    J Pharmacol Exp Ther; 1998 Jul; 286(1):136-41. PubMed ID: 9655852
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regulation of cellular immunity by activating transcription factor 4.
    Mukherjee D; Bercz LS; Torok MA; Mace TA
    Immunol Lett; 2020 Dec; 228():24-34. PubMed ID: 33002512
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Role of phosphatidylinositol 3-kinase in the immune system].
    Koyasu S
    Tanpakushitsu Kakusan Koso; 2006 Sep; 51(11):1569-79. PubMed ID: 16944841
    [No Abstract]   [Full Text] [Related]  

  • 26. The innate immune system contributes to tissue-engineered vascular graft performance.
    Hibino N; Mejias D; Pietris N; Dean E; Yi T; Best C; Shinoka T; Breuer C
    FASEB J; 2015 Jun; 29(6):2431-8. PubMed ID: 25713026
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dynorphin opioid inhibition of cocaine-induced, D1 dopamine receptor-mediated immediate-early gene expression in the striatum.
    Steiner H; Gerfen CR
    J Comp Neurol; 1995 Mar; 353(2):200-12. PubMed ID: 7745131
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Nalpha-benzylTyr1,cyclo(D-Asp5,Dap8)]- dynorphin A-(1-11)NH2 cyclized in the "address" domain is a novel kappa-opioid receptor antagonist.
    Patkar KA; Yan X; Murray TF; Aldrich JV
    J Med Chem; 2005 Jul; 48(14):4500-3. PubMed ID: 15999987
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Heterodimerization of human apelin and kappa opioid receptors: roles in signal transduction.
    Li Y; Chen J; Bai B; Du H; Liu Y; Liu H
    Cell Signal; 2012 May; 24(5):991-1001. PubMed ID: 22200678
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Structure-activity relationships of arodyn, a novel acetylated kappa opioid receptor antagonist.
    Bennett MA; Murray TF; Aldrich JV
    J Pept Res; 2005 Mar; 65(3):322-32. PubMed ID: 15787962
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Single-cell RNA sequencing to explore immune cell heterogeneity.
    Papalexi E; Satija R
    Nat Rev Immunol; 2018 Jan; 18(1):35-45. PubMed ID: 28787399
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular simulation of dynorphin A-(1-10) binding to extracellular loop 2 of the kappa-opioid receptor. A model for receptor activation.
    Paterlini G; Portoghese PS; Ferguson DM
    J Med Chem; 1997 Sep; 40(20):3254-62. PubMed ID: 9379445
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Crosstalk between innate and adaptive immunity].
    Yoshikai Y
    Nihon Rinsho; 2006 Jul; 64(7):1223-8. PubMed ID: 16838637
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analysis of binding domain and function of chimeric mu/kappa opioid receptors to ohmefentanyl stereoisomers.
    Feng YP; Chen LW; Zhou DH; Chen J; Xu XJ; Chi ZQ
    Acta Pharmacol Sin; 2001 Nov; 22(11):981-5. PubMed ID: 11749787
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of dynorphin a from zebrafish: a comparative study with mammalian dynorphin A.
    Gonzalez-Nuñez V; Marrón Fernández de Velasco E; Arsequell G; Valencia G; Rodríguez RE
    Neuroscience; 2007 Jan; 144(2):675-84. PubMed ID: 17069980
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dynorphin A1-13 causes elevation of serum levels of prolactin through an opioid receptor mechanism in humans: gender differences and implications for modulation of dopaminergic tone in the treatment of addictions.
    Kreek MJ; Schluger J; Borg L; Gunduz M; Ho A
    J Pharmacol Exp Ther; 1999 Jan; 288(1):260-9. PubMed ID: 9862779
    [TBL] [Abstract][Full Text] [Related]  

  • 37. NMR and structural model of dynorphin A (1-17) bound to dodecylphosphocholine micelles.
    Tessmer MR; Kallick DA
    Biochemistry; 1997 Feb; 36(8):1971-81. PubMed ID: 9047294
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tetraspanins in the immune response against cancer.
    Veenbergen S; van Spriel AB
    Immunol Lett; 2011 Aug; 138(2):129-36. PubMed ID: 21497620
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of recovery from immobilization stress on striatal preprodynorphin- and kappa opioid receptor-mRNA levels of the male rat.
    Lucas LR; Dragisic T; Duwaerts CC; Swiatkowski M; Suzuki H
    Physiol Behav; 2011 Oct; 104(5):972-80. PubMed ID: 21723305
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mast cells in allergy: innate instructors of adaptive responses.
    Stelekati E; Orinska Z; Bulfone-Paus S
    Immunobiology; 2007; 212(6):505-19. PubMed ID: 17544835
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.